<SEC-DOCUMENT>0001628280-25-043489.txt : 20251001
<SEC-HEADER>0001628280-25-043489.hdr.sgml : 20251001
<ACCEPTANCE-DATETIME>20251001171010
ACCESSION NUMBER:		0001628280-25-043489
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20251001
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251001
DATE AS OF CHANGE:		20251001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vanda Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001347178
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				030491827
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34186
		FILM NUMBER:		251365484

	BUSINESS ADDRESS:	
		STREET 1:		2200 PENNSYLVANIA AVE NW
		STREET 2:		SUITE 300E
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20037
		BUSINESS PHONE:		202-734-3400

	MAIL ADDRESS:	
		STREET 1:		2200 PENNSYLVANIA AVE NW
		STREET 2:		SUITE 300E
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>vnda-20251001.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:68a24a9a-f051-4fcd-9851-c010c46188f0,g:6054b90a-d678-49dc-b24d-57ff828f8c5c,d:e47ec9638103456d9861f008a6ebee36-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vnda-20251001</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001347178</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-23">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vnda-20251001.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001347178</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-10-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie47ec9638103456d9861f008a6ebee36_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">October 1, 2025</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">VANDA PHARMACEUTICALS INC.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.052%"><tr><td style="width:1.0%"/><td style="width:34.212%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.058%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.214%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-34186</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">03-0491827</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File No.)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">2200 Pennsylvania Avenue NW</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 300E</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Washington</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">DC</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">20037</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">202</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">734-3400</ix:nonNumeric></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Not Applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(Former Name or Former Address, if Changed Since Last Report)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.292%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.942%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.815%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.943%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">VNDA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:1pt;margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ie47ec9638103456d9861f008a6ebee36_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;8.01.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other Events.</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2025, Vanda Pharmaceuticals Inc. (&#8220;Vanda&#8221;) issued a press release announcing that it had reached a collaborative framework with the U.S. Food and Drug Administration for the resolution of certain disputes regarding Vanda&#8217;s drugs, HETLIOZ</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (tasimelteon) and tradipitant.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The full text of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.637%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.01.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Exhibits</span></div><div style="text-indent:9pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.918%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="vnda8-k1012025exhibit991.htm">Press release of Vanda Pharmaceuticals Inc. dated October 1, 2025.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ie47ec9638103456d9861f008a6ebee36_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:6pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:5.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.024%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">VANDA PHARMACEUTICALS INC.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Timothy Williams</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Timothy Williams</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel and Secretary</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>vnda8-k1012025exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ibd7a922a15c649948f2b81c78ad5602d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><img alt="vandaq32019earningsca_imaga.jpg" src="vandaq32019earningsca_imaga.jpg" style="height:88px;margin-bottom:5pt;vertical-align:text-bottom;width:264px"></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration</font></div><div><font><br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">WASHINGTON, Oct. 1, 2025 &#47;PRNewswire&#47; -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq&#58; VNDA) today announced that it has agreed on a collaborative framework with the U.S. Food and Drug Administration (FDA) for the resolution of certain disputes regarding HETLIOZ</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (tasimelteon) and tradipitant.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Key features of the agreement include&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The FDA will conduct an expedited re-review of the partial clinical hold preventing long term clinical studies of tradipitant for the treatment of motion sickness by November 26, 2025. The FDA will continue its review of Vanda&#8217;s New Drug Application (NDA) for this indication, with the existing Prescription Drug User Fee Act (PDUFA) target action date of December 30, 2025. </font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The FDA will conduct an expedited re-review of Vanda&#8217;s supplemental New Drug Application (sNDA) for HETLIOZ</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of jet lag disorder by January 7, 2026, including consideration of alternative or narrowed indications focusing on the sleep-related aspects of jet lag disorder. During the re-review, Vanda and the FDA will seek a temporary pause of the Part 12 proceedings that result from the D.C. Circuit&#8217;s recent decision in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vanda Pharmaceuticals v. FDA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, No. 24-1049 (D.C. Cir.).</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The FDA and Vanda will seek a temporary pause of the ongoing administrative proceedings before the FDA Commissioner for Vanda&#8217;s NDA for tradipitant for the treatment of gastroparesis, until January 7, 2026.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vanda and the FDA have sought a pause in Vanda&#8217;s lawsuit challenging the FDA&#8217;s practice of taking up to 12 months&#8212;rather than the statutory 180 days&#8212;to decide new drug applications, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vanda Pharms. Inc. v. FDA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Nos. 24-cv-351 and 25-cv-536 (D.D.C.).</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vanda will dismiss its lawsuit challenging the FDA&#8217;s partial clinical hold preventing long term studies of tradipitant for the treatment of motion sickness, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Linn v. FDA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2&#58;25-cv-32 (M.D. Fla.).</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vanda will dismiss its lawsuit regarding Vanda&#8217;s request to provide information to prescribers and patients regarding the efficacy of HETLIOZ</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> in jet lag disorder, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vanda Pharms. Inc. v. FDA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, No. 4&#58;25-cv-1648 (S.D. Tex.).</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">About Vanda Pharmaceuticals Inc.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X &#64;vandapharma.</font></div><div style="margin-top:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Various statements in this press release, including, but not limited to statements regarding the actions that the FDA is expected to take, and the timing thereof, with respect to the NDA for tradipitant for the treatment of motion sickness and the sNDA for HETLIOZ</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of jet lag disorder, and the actions that Vanda and the FDA are expected to take with respect to certain of their ongoing administrative proceedings and litigation, are &#8220;forward-looking statements&#8221; under the securities laws. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements are based upon current expectations and assumptions that involve risks, changes in circumstances and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda&#8217;s forward-looking statements include, among others, the FDA&#8217;s ability to conduct expedited re-reviews of the partial clinical hold on tradipitant for the treatment of motion sickness by November 26, 2025 and the sNDA for HETLIOZ</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of jet lag disorder by January 7, 2026, the FDA&#8217;s ability to complete its review of the NDA for tradipitant for the treatment of motion sickness by the existing PDUFA target action date of December 30, 2025, and the results of the FDA&#8217;s review of the NDA for tradipitant for the treatment of gastroparesis. Therefore, no assurance can be given that the results or developments anticipated </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">by Vanda will be realized, or even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Forward-looking statements in this press release should be evaluated together with the various risks and uncertainties that affect Vanda&#8217;s business and market, particularly those identified in the &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221;, &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of Vanda&#8217;s most recent Annual Report on Form 10-K, as updated by Vanda&#8217;s subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the U.S. Securities and Exchange Commission</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which are available at www.sec.gov.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this press release is provided only as of the date of this press release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate Contact&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Kevin Moran</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President, Chief Financial Officer and Treasurer</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Vanda Pharmaceuticals Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">202-734-3400</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">pr&#64;vandapharma.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Jim Golden &#47; Jack Kelleher &#47; Dan Moore</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Collected Strategies</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">VANDA-CS&#64;collectedstrategies.com</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">SOURCE Vanda Pharmaceuticals Inc.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>vnda-20251001.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:68a24a9a-f051-4fcd-9851-c010c46188f0,g:6054b90a-d678-49dc-b24d-57ff828f8c5c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vnda="http://www.vandapharmaceuticals.com/20251001" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.vandapharmaceuticals.com/20251001">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vnda-20251001_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vnda-20251001_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.vandapharmaceuticals.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>vnda-20251001_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:68a24a9a-f051-4fcd-9851-c010c46188f0,g:6054b90a-d678-49dc-b24d-57ff828f8c5c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1372ef45-efd2-47f2-87a2-8098ae934c20_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_adce15f1-2dcc-43fe-b1ac-4f91e4678756_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_06db419d-d406-4a32-8629-1f5ce093423b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a5981c1f-5495-4070-ac2c-3941e799243d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_35eabb17-343a-4ad0-99f7-3350b79bf142_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_21202fbe-b4e3-4798-b4da-8488ae03d4fc_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_13b9a672-ce27-4578-bf25-5e310ace5876_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3f57d056-282a-4112-aa78-d6f83aa4ea0b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_20d19e26-9564-4c9f-92d1-d3dd47a81c57_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ecdec84d-7918-4e71-bf59-b412fc181a00_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_220ed907-2f79-468e-8d8e-8c66f801d6ed_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_d5ed17db-8e41-4b98-907e-0e2da7f80c89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_703d29ef-59a1-4476-b8a7-8ce57d0c16a9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5eb0d779-becf-498a-9d0f-fa5dc92534fc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_012636c2-3bb6-410a-ac0c-ce3ff64b4fc4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_84032e14-6d9f-45c4-9ee6-fc7467232e77_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_dd3e697d-5f70-4cdb-ad0a-15f90b8d901a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_08e560e9-50e9-4e39-8098-74e4b7103566_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5700fcfb-1102-4b48-8469-32b377939b32_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_03bc3dee-d94d-46ee-827e-403c20daa8ec_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_0e248293-9d60-41be-bae1-c74adb2062cd_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7b9e1ea4-bad2-44d7-9faf-7e2c32e2a136_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1471960c-bf5d-4076-9bd1-691b6057138e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>vnda-20251001_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:68a24a9a-f051-4fcd-9851-c010c46188f0,g:6054b90a-d678-49dc-b24d-57ff828f8c5c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CoverPage" xlink:type="simple" xlink:href="vnda-20251001.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.vandapharmaceuticals.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f89ce617-939a-44e4-8e6d-20bdd5cb96f7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_DocumentPeriodEndDate_f89ce617-939a-44e4-8e6d-20bdd5cb96f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7dce99ba-d44a-4027-987d-dd94bf4e9f20" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityRegistrantName_7dce99ba-d44a-4027-987d-dd94bf4e9f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b1135433-2a02-4adc-98d3-91976b6b9b43" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityAddressAddressLine1_b1135433-2a02-4adc-98d3-91976b6b9b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_eaf6c9ad-16df-4d19-827e-547bcec76154" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityAddressAddressLine2_eaf6c9ad-16df-4d19-827e-547bcec76154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f09c8358-263d-44f7-bd5a-83e04193907a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityAddressCityOrTown_f09c8358-263d-44f7-bd5a-83e04193907a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d7758fd8-cd98-4f7c-b7ba-3f8ce2e6600f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityAddressStateOrProvince_d7758fd8-cd98-4f7c-b7ba-3f8ce2e6600f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d08fc438-6331-40c9-8c12-578e98e752e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityAddressPostalZipCode_d08fc438-6331-40c9-8c12-578e98e752e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7cc466d3-5336-40a1-90b8-d7d5f99f9913" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_CityAreaCode_7cc466d3-5336-40a1-90b8-d7d5f99f9913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2590bf3b-b4a7-44b4-a435-702badc9ee6d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_LocalPhoneNumber_2590bf3b-b4a7-44b4-a435-702badc9ee6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_34d9f8ef-9e89-4238-9f2d-71615a846f47" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityEmergingGrowthCompany_34d9f8ef-9e89-4238-9f2d-71615a846f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8142b675-c36a-4449-b90b-33358929029c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_Security12bTitle_8142b675-c36a-4449-b90b-33358929029c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_28da88f5-3955-41e2-a8b6-39d62ce71986" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_TradingSymbol_28da88f5-3955-41e2-a8b6-39d62ce71986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_adb49f77-82ee-4e81-a679-1e06cd885a1d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_SecurityExchangeName_adb49f77-82ee-4e81-a679-1e06cd885a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9ae48d07-5853-43fd-8ebb-8e452097ae70" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_WrittenCommunications_9ae48d07-5853-43fd-8ebb-8e452097ae70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_63490c0f-0fc9-4b66-9471-17174ad86b50" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_SolicitingMaterial_63490c0f-0fc9-4b66-9471-17174ad86b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_d889905a-5e52-4d2b-95bb-d4003d8e6dcb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_PreCommencementTenderOffer_d889905a-5e52-4d2b-95bb-d4003d8e6dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_201c3cd3-1dc2-47d3-8c4b-43ed7a55b1fe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_201c3cd3-1dc2-47d3-8c4b-43ed7a55b1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_088fd812-9116-4736-a758-4e2f8bd836bd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityCentralIndexKey_088fd812-9116-4736-a758-4e2f8bd836bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ddf7f0a9-5554-4ea4-aa53-4fc1165ba16d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_AmendmentFlag_ddf7f0a9-5554-4ea4-aa53-4fc1165ba16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ad680036-3123-4367-83f6-fa3da4731354" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_DocumentType_ad680036-3123-4367-83f6-fa3da4731354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_09a440fc-a808-4fdd-8825-303830abaf07" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityIncorporationStateCountryCode_09a440fc-a808-4fdd-8825-303830abaf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_34caa61f-6a2d-4944-9187-d330649fa441" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityFileNumber_34caa61f-6a2d-4944-9187-d330649fa441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_413509fa-7bc0-4553-a62b-13115a642d7b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_30030e40-e258-4273-8d0b-fcef71899947" xlink:to="loc_dei_EntityTaxIdentificationNumber_413509fa-7bc0-4553-a62b-13115a642d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>vandaq32019earningsca_imaga.jpg
<TEXT>
begin 644 vandaq32019earningsca_imaga.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M^RO?-WL^7]FN]]W Z;&SMY)I#YZ8T+D"O$D"@'F:#IFYGCM;=[F7^SC0L?L
MKUJY[NW-D]Z;IW%N[,R>7*[FS>3SN08$E!592LFK)8X@WZ((6ET1J.%10
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MCNH:K9M5U#L[?$LN^-G9O/9K^-9[-[NQ]<JUV/W=@X!1"#!P^./PEE8L2QN
M)^]L_;/ESF[EQMUW5KD70N7C_3=572JH1@HV>X^?6,7N][O<U\C<UKLNRK:&
MS-I')^I&S-J9I <B112BB@IZYZ)S\4O^%,W=T/;^$H?F'LCKS(]*9E?X7FLY
MU+M/-X;>.RJNHG@%+NI*'([KSM/N?#4"AQ6X^-(:MH7\M.[RQ"FJ!-S#[$[4
M=M=^6I9EW1<JLSJR.!Q2H12K'\+&HKA@ =2A#E7[R>]#=TCYO@MVV9^UF@1E
MDC)(H]"[!U'XD #4RI)&EMRC8'8&Q^U=F;<[$ZVW7@=\;%W=C8LOMK=>V<E3
M9;"9G'3,Z"HHJZDDDAD\<T;Q2I</#,CQNJNC*,9+RSN]ONGLKZ-XKN-J,C A
ME/H0?VCU&1CK,&PO[+=+./<-NECGL95U(Z$,K#U!'[#Y@@@Y'2P]INE?7O?N
MO=>]^Z]UK&?SI/YO'RL^ ?RDV%T[T9C^IJO:6Y>@MK=EY&3?FT,SN#+KN+,=
MB=I[6JTIJS';LP,$6-&,V;2%(C"SK*9&+D,%6>/:[VWY>YPV";<]V:Y%S'>/
M$/#=572L<3BH*-FKG->%,=8T^\GNUS3R'S/!L^QK:&TDL$F/BQL[:VEG0T(D
M44I&N*<:YZN7_EQ?(3?GRK^%'0WR![.AP$&^^R<!N')[AAVMCJG%8!*C%[XW
M1MZF&.Q]97Y2IIHS08>(L&J)"9"QN 0!&/.^S6?+W--YLU@7-I ZA=9!:AC1
MC4@ '+'R'4Q>W?,%]S3R98;_ +F(Q?7,;E] *K59'04!+$84>9SUKI_.O_A0
M1\R_C#\O._.@=@]9_&3+[.ZLWY5[7V_DMW[,[4K]S5F/IZ*AJ4FS-9ANY\!B
MZBL+U+ M!14Z6 ] ^IFOE+V;Y8W[ENSWB\GOUN;B$.P1X@H))':&@8@8\V/V
M]8\\\>_G.'+/-M_L-A;;8]G:SE$,D<Y<@ 'N*W"J3GR4#Y=%,_Z"@/GU_P ^
MB^('_H ]S_\ V_\ V(O]83D__E)W+_G)!_VS]!7_ ()GGS_E$VC_ )Q7'_;5
MU[_H* ^?7_/HOB!_Z /<_P#]O_W[_6$Y/_Y2=R_YR0?]L_7O^"9Y\_Y1-H_Y
MQ7'_ &U=>_Z"@/GU_P ^B^('_H ]S_\ V_\ W[_6$Y/_ .4G<O\ G)!_VS]>
M_P""9Y\_Y1-H_P"<5Q_VU=9J?_A4#\\EJ(&J^G?B--2K-$U3#3[([DI:B6G#
MJ9HH*F3O>KCIYI([A7:*548@E& L=-["<HT.FYW(-3%9(3_+Z<5_:/MZVOWF
M>>@P+V>TE:YI'< T^1^I-/MH?L/1KNEO^%35><K04'R(^*]#_!IYT7);IZ9W
MK4)D<;364/)1[$WK234^7EO<A7W#1 "PN3S[#VZ?=_3PR^R[@?% PDZ"A/SD
M0X_YQMT*MF^\_)XJQ\P[6O@DY>WD-0/E%("&_P"<J];._P 7?EKT%\R>LZ3M
M?X^;^QN]MLR3"AR](@>@W+M+-",2R[?WAMNK$>4V]F(T.M4G01U$)6:G>:!T
ME:!M_P"7-XY8OSMV\PM%/2H/%77^)&&&7[.!P0"".LE^6.:]AYPVT;KL$ZSV
MU:,.#QM_!(A[D;Y$4(HRDJ029#V1]"+KWOW7NBQ?,;Y4=??"_P".W8WR%[&D
M6;%;*Q+?P3;\=5'29'>F\<C>DVKLS$R.DQ6MS^6=(WE$<@I*82U+J8H9"#[E
MGE^\YHWJ#9;'$DK=S4J$09=S\E&:5%311DCH-<W\T6')O+UQS!N.8H4[4K0R
M2'"1KQRS4%:'2*L113UI:2?\*6_YB+2.T>"^.$:,[,D?^C;=3^-"Q*IK;L:[
M:1Q<\GWE$/8ODNF7OJ_\U4_ZU=8:G[R'N"341[<!_P T7_ZW=;?G\N;YN;2^
M?/Q>V5W?A%H,7O!$.U>V]FT<P<[-[*PT%.,[011//45$>$S$<T63Q32.\CXV
MLA$A\RRJN-G.W*MSR?O\NU2U:V^.%S^.)B=)\AJ7*O3\2FF*=9;^WG.MISWR
MQ#O<.E;OX)XP?[.90-0XDZ6PZ5-=#"N:@'L]A+H<=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T'':W7%%VSLVLV'E\MD\3@,
MU5T!W V&:GAR>0Q=!4ID/X73UE1#4I0I65U+ )I!&[-3B2,6UZE"7._*5MSS
MR_)RS?SS0;7<.GC^%I$CQHP?PU=@P0.ZIK;224#(*:M00[C8IN5J;.5F6%R-
M6FE2 :T!-:5(%<<*CSZJG[DG_E&]*YRNZ_[0^1/777^^<94+C\OA!W&,EN_
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M[^MG,O[GV]Z[%MS,BT.))N$LGH0M/#C.<!F4TDZV6/Y%W\OA/AG\7:3L3?\
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MH>NC=K=6]]:QWMFZR6DR*Z.IJK(P#*P/F""".E![9Z?ZT%/^%+7_ &\4PO\
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M9]BN7"U[8KZ-HB1Z)<Q*T4I/E^G&OJW4BV.U;'S%$;GE'<[6]C J4UC6H_I
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MTY*13T'!@/TW/^F4:"3@:4'%NLP?NV\Z>-:S\CWS_J0UGMJGBC']:,?Z5B)
M!4G7(>"];9WO'7K*SH'OD!T9U]\ENF>Q>BNTL4N7V-V7MJNVYF85$8JZ)IPL
MV,SF)FE21:3.;=RT$%?0SZ3X:NGC>QTV]F>S;M>;%ND&[;>VF[@D#+Z'U4^J
ML*JP\P2.BC?]DL.9-GN-CW1==C<QE&'F*\&7T9& 93Y, >OFX5M/W_\ RC?G
M^R1N:;LOXZ]AK-3RJT]'@.S=@9",/&2P$DC[0[2V%DM,BV-131UC*1'50$)G
M K;/[C\G5.;&]ASYM%(/^?XI!CR)7S4YYT.N_>T_/M!C<MON,<0LT1_ZQSQ'
M/FH:F&7'TB?COWSU]\G>D^M^^NKLFN4V1V9MJCW#BG9HS5XZH<R4N9V]EDB9
MTI\YMG-TU1CZZ($B*KII%!(%SA!O6T7FP[K/M&X+INH)"I]#YJP_HLI#*?,$
M==%>7]]L.9=EMM]VQM5E<QAU]0>#(WHR,"C#R8$=#/[*^CGJD7^>;_,);X6_
M%^?877N;^P^0/R%ILMM#8TU#41C)[*V='%#!OKL0JI,U)4TM!6KCL3*#'(,G
M6+41%_LIE$J^T_)G]:-_%W>I79K(AY*C#O\ Z''\P2-3C^%=)IJ'4*^]W/\
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M@:>?_"EK_MXIA?\ Q7#K3_WJ>Q_>2OL7_P J4_\ SW2_\<BZQ$^\A_T\)/\
MI70_\?FZVS/Y0O\ V[2^'/\ XB#'?^[;+^\=O<G_ )7K<_\ GI/^!>LJ_:7_
M *=OL_\ SR#_ (\W5C_L$=2+U47_ #2/Y3'4O\P_93[@Q@Q/7/R6VKC*B/8W
M:L./1(=Q004TK46Q>S31P-6YG:,U45^WJ@LU=A79I:8/&]12U,C\@>XNX\EW
M7@OJGV*1OU(J_#G,D5<*].(PK\&H0K+$WN=[4[5[@V7U$>BWYDB4^%/3XP!B
M*:@JT9/!LM&:E:@LC:1_5O;GS1_D_?+#,TL%'D^M^S-GUM-B^Q.LMS/4UVP>
MR]M?NS45+G:3&5\..W9M?)TE4]1BLI15'D@,HGHZB.2Y]Y4[AMO*_N5RZK$K
M/82@F.5:"2)O,J2*HX(HZ,,THP(ZPMVO=N<O:/FIT4-;;E"P66%ZF*9/(,%(
M$B,#5'4U%=2,#UOV?R__ .8CT5_,*ZICWUU?7_P+>^!AHZ;L[J3-UM*^[M@Y
MJ>%"[,D?B.=VE7SZ_P"&YB&)(*Q%*2)!51STT.'_ #CR7NW)FX_27XUVKDF*
M90=$B_\ /KC\2$U'D2I#'/#D+W!V/W VKZ[;&T7J ":!B/$B8_\ 'HR?@D H
MPP0K!E74\_X5 ?\ 9?747_BH&P?_ '\_?_O(?V$_Y4^Y_P"EE)_U8M^L5OO,
M_P#*^6G_ $J(O^TBZZV;/Y)O_;KCXC?^&AO+_P!^KOWW!'NG_P K_N7_ #53
M_JU'UDI[+_\ 3L=I_P":,G_5^7K1T_F\_P#;RWYC?^)@R7_NJQ/O*_VW_P"5
M%VS_ )YA_A/6$WNU_P!/(WC_ )ZS_P =7KZ/7QZ_YD%T=_XA_K3_ -XO"^\(
M]Z_Y+%W_ ,],O_'VZZ)<O_\ )!LO^>2'_JVO0P>RSHWZ][]U[KWOW7NN$DD<
M,<DTTB111(TDLLC*D<<:*6>21V(5$102238#WL DT''K1( J< =?*8Z;_P!_
M5\NNJ_X#_E_]Y/D=L?\ @O\ RB_>_P 8[-Q?\._X&_;_ &_W'W"?YWQZ+^K3
M8VZ$[G_B_+=QXV-%C)J\Z:8C7A6M*>77+79_\:YMM? [O$W&/3Y5U3+3C2E:
M^=/GU]17O'N?8'QVZB[![N[2S,>!V#UIMJOW/N+(/9IFIZ15CI,;CX"RM6YG
M-Y&:&BH:9/W*JMJ(H4!=U'O 7:=KO-ZW*':MO77>3R!5'S/$GT515F/DH)/#
MKIOO>\V'+VTW&];HXCL+:,NY^0X #S9C15'%F( R>OFR]H[Q^3'\W3YS9G+[
M7VU6;K[4[CS=;1; V%!E*>+$;'V#MJ@K:S#;;BRV4EH,3B<#M+;5$\U;62FF
MBJ:LU%5(//4OJSBV^VV+VWY36.XD$>WVR R24-9)&(#-05)9V-%45(%%&%ZY
MR[G><R>[/.[RVT9EW2\<B*+4-,42 E4U-156- 2S&@+:F/<QJ>3;?\DG^<WL
MW&_P;:&W\CM3$">6J_A6V_DQLW!8W[J<()ZG['%[\I:7SS"-=;Z=3:1<\>PI
M/[J>V%T_BW+K))2E6M78T]*F,GH;VWLM[Q6<?@VD;10UKI2\C45/$T64"O3_
M /\ #.G\\3_CKO#_ -*QV]_]L3VS_KF>U/\ PK_LD;_K7T__ *T/O9ZS?]ER
M?];>FG._R5?YTVZ,55X+<V*S6XL'7B):[#9WY/[2R^*K5@GBJH%J\=D-_5%)
M4B&I@21 Z-ID16'(!]N1>Z7M=;R":!E24<&6U<$>6"(P1C'34_LS[RW41@N5
M>2!N*M>QLIH:BH,I!R ?MZKSS6S/EK_*A^7>P\KN_;T_67>75==MWL/ 0G)T
M>9V_N7;N5BFBFIX\SMS(3XW<6T=T8TUV'RD=/4FZFKI)"DJ.JC.*ZY<]P^6Y
MH[9Q/M-P&C;!5E8>>EA570Z72H_A85!'4?S6?-?M7S;!+=QFVWNU9)4[@R.C
M5J-2$AXW&J-P#_&AH0:?1]^(WR=Z_P#F+\>NM?D+UM4+_ M^X.*IR&&DJ(Y\
MCM'=-$QH=U;-S.@)IR>V\W!-3L^E4J(E2HBU0S1NV$?,>PWG+.]3[+?#]:%Z
M!O)T.4=?DRT/R-0<@]=$N4^9MOYOY?MN8-M/Z$Z5*UJ8W&'C;^DC CYBC#M(
M/1D?9'T(^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7V_X4
M9_%?<G?'PNPO;.RL?59?<7QCW=5[YS.,HXIJFIGZQW)C4PN_*ZFI8%9I)-O5
M-)B\I4.?1!C**KD/"^YD]D^8(-HYH;;KI@L%_&(U)P/%4ZHP3_2!=!ZLRCJ
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M%\].'8?Q:/-3U)'W=.0/IX&Y\W-/UI0T=H",A/ADF%>!?,:'CI$G%7!Z2O\
MPI!_F)A4HOY?_4^=82%L1NWY(Y/&U#*5C,=+F=C=522PS699A)#G<M$R?1<:
MBO8U47M1[(<E9/..XIC*6P/YK)+_ (8T/^G-/A/27[Q7N%0+R%M3Y[9+P@_8
MT4''SQ+(*?[[%?B'0L?\)R_Y='^CO9%1\[^V<"\.^.R,56X'H/%Y.FTR[=ZT
MK=,6;[#2"IC\E/E>P9(C2XZ951TP4<DB/)!E"%+O>SG;ZVZ'*.W/6T@8-<$'
MXI1\,>.(CXL/]^$ @&/HV^[Q[>?N^R//.ZI2]N4*VJL/@A/Q2YX-+\*''Z0)
M!*R];4'O'[K*#KWOW7NO>_=>ZK(_FP? 3#?S /BON#8N/IJ.G[GZ_P#OM]]%
M[@G,-.8-Y4M"\=7M&OKG"O#MO?\ 01_858+B&&J%)6NLC4:(1Y[=\X2\G<P)
M=N2=KFI'.O\ 0)PX'\49[AYD:E%-1ZC7W4Y#AY]Y7DL8P!O%O66V<XI(!F,G
MR24=K>0;0Y!T =:;'\GSYX[@_ET_+RJV?VP^4VYTWV7F8^K^^MN9R.KH9-@;
MAQ.5J,;A]^5N,F\4E!E^O<Y)/39-)$,BXJIK4\;3I#HR;]RN48>=>6Q<[=I?
M<X%\6W9:'Q%8 M&#YB1:%?Z87-":X?>T7/5Q[>\VFSW75'L]R_@W2-4>$ZL0
MLI4\&B:H>HKH+BA8+0;O^%*<T-3_ ##MOU%/+%/3S_&OK":">&1989H9=S=B
MO%+%*A9)(I$8%6!((-Q[*?8T%>2W5A1A?2_\<BZ.OO'D-[@1LI!4[;#0_P"W
MFZVT?Y0O_;M+X<_^(@QW_NVR_O'7W)_Y7K<_^>D_X%ZRL]I?^G;[/_SR#_CS
M=6/^P1U(O7O?NO=5X?S$_P"6_P!(_P Q'JK^Z>_Z==L]F;7I,C-U1V]BJ..7
M<.R<M5Q:OLJ^+5 =Q;+R=5'&<ABI9$64*)()*>I6.=!IR5SONO)>X?4V9\2Q
MD(\:$GM<#S'\+@5TN!C@05J#'_N#[=;+[@[7])?CPMRB!,$ZCOC8^1X:XR::
MT)SQ4JP##0BWELKYH_R?_EO3M]WE>K^V-DU-1-M?>6&2?(;![1V94RQK+4XN
M:OI(<9O;8>XH%1:NBJH1)3S+XJF&GK(-,67UK=<K^Y7+APMQMTH&M&Q)$X\C
M0U21?)@:$94LIS@E>67.7M'S8,O:[K"3HD6IBGC/FM1IDB<4U*PJ#A@KKA1_
MS1?GKC?YB?;O3/>$6RY]@;GV]\<=J]7]B;<%6,AA(M\[?[)[7W%7U^T\@Y%;
M4[:RN(W=0U$*5*+44LLDE,[3^ 5,['('*#\E;;=;291-;O?/+&U*-X;10J X
MX!@48&F" &%*Z0H]SN>H_<+=K/>Q";>ZCVY(94K5?%2:=R8SQ*,LBD:LJ25.
MK3J;=Z_DF_\ ;KCXC?\ AH;R_P#?J[]]XJ>Z?_*_[E_S53_JU'UFK[+_ /3L
M=I_YHR?]7Y>M(G^<CA,I@/YF_P OZ/+T<U%4U79=/FZ>*9"C2XO<6T]MY[#5
MB7 U0UV*R,,R$<%7'O*KVRECFY#VUHR"H@*_FKLK#\B".L*_>"&6#W*W=)05
M8W(85_A>-&4_FI!ZW!_C7_.V_EJ_[+_TU1[I^1=#L+=&&ZTV5@-R;/W1LGL5
M<UM_.X+;F.Q64Q]3/B-HY7#UR15E(WCJ*2JGIYHR&5[W48U[[[5\\_OFZ:WL
MC-;M.[*Z/'I968D$5<,,'((!'677+GO3[<?N&S2ZW%8+I+:-7C>.74C*@5@2
ML;*<C!5B"//H;_\ A[+^5Q_WESM#_P! WM7_ .P+V4_ZUG/_ /T;9?\ >XO^
MMG1U_KT>V/\ T=H?^<<__6KKW_#V7\KC_O+G:'_H&]J__8%[]_K6<_\ _1ME
M_P![B_ZV=>_UZ/;'_H[0_P#..?\ ZU=1:W^=]_*RQ]+-63_+;;4D4 5G2BZ_
M[BR=4P9U0>&AQO7576U!NPN(XV(%R> 3[LGM3[@.P4;=)4^LD('[3( /V]5?
MWK]KXU+MNT=!Z17#']@B)/Y#JH;^8I_PHKZ9W%TYOWIOX6XS>FY-X]@[=RNT
M:SN/<^$EV=MS9V$SU-)C<MD=IX;)2+NO,;H?%SS1TDE52XV"@FDCJ :AHS"9
M(Y*]E-TAW.'<^:&B2VA<.(5;6SLIJ [#L5*TK0L6%5Q6O42^X7WA=FN-GGV?
MDU9I+RXC:,W#KX:1JPHQC4][/I)"EE0*2&[J:>JE?Y#/PMW=\F/FUL'MFHP]
M3'T]\8=PX?M3>&YI4,5'-OC"229/JW:6,F>.5*K-U6[:*GR4T8&F+&8ZH+/'
M))3B21O=WFBVV+E6;;E8?O._1HD7S\-L2N?10A*CU9A@@-2*/8ODV[YDYT@W
M5D/[HVR19Y'\O%7,$:^K&0!R/)$:I!*U.)_PHM_F*#MGLR#X0=4YT3==].YE
M<GW5DL;5,8-T]O4@EAI]F3-$!'48OK*"1A4IK96SD\L<D:RXZ-B&?93DK]W6
M!YKW%*7MRM( 1\$)XO\ (R^7_"P"#1ST+_O"^X7[UW(<E;4]=OLWU7!!P\XP
M(_FL(^+/]J2"*Q@]6M?\)_/Y=#?&'HA_DYVE@S2=Y_(?!T51@\=DJ0PY3KKI
MN6:/(X'#/'*/+29G?TL4&8R"DADI5Q].Z13P5"M'OO'SM^_MW_<.WO7:;)R&
M(.))N#-\UCRB_/602"O4I^PGMY_5G8_ZR[HE-[W! 5!%&BM^*K\FEQ(_HOAJ
M0&5J[#WN%^L@>O>_=>Z][]U[JEC^=Q_+J3YQ_&>?=G7V%%7\C.AJ3+;JZU%)
M%&M?O?;TB0S[QZPGDTEJF7,T5&*S$*URF8I8H5:**KJ7,H^U?.IY3WT6]XU-
MDO"$EKPC;\$ORTDT?^@2<E5'4->]/MZ.=N6S=;>E>8K$,\-.,B<9(3ZZ@-4?
M_#% ! =CUK:_R#/YA\OQ.^1+_'/M',O0=%_(G/8W#";*U$D%!USW&S1XC:^Y
MG\\@IL9BMU7CPV9=D0*?L:F:6.&ADU3C[P<ECF+9?WWMZUW:R0M@9DAXLOJ2
MGQI_MU )<=8Y^Q'N">5>8?ZN[F^G8]PD"]QH(;CX4?.%5\1R''X&)"H>M_'W
MA[UGCU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=1JVBH\C1U
M>/R%)35]!7TT]%74-;!%54=;1U4305-)5TTZO#44U1"[))&ZE74D$$'W969&
M#H2'!J",$$<"#Y$=5=$D0QR -&P(((J"#@@@\0?,=:E?\Q3_ (3@T^X,ANCN
M#X$Y/'X:OKI:[.9+XW;HK*?'8*6MGD-1-1]2[NJ6@HMOP2LQ\&'S#+10LQ$5
M?3P+%3)D7R5[W-"D>V\WJS(**+E!5J<*S(,M\W3N/FC&K'%+W"^[LMQ)+N_(
MC*DC$L;-R M3DB"0T"#TCD[1Y2*M%&I#V;U;V1TQO7-=<]L[&W1UUOO;M1]O
MF=J[PPU=@LU1,PUP3-1U\,,DU%60D2T]1'KIZF%EDB=XV5CD;8;A8[I:I>[=
M+'/:.*JZ,&4_F/,<"#D'! /6)^Y;7N.S7K[=NL$MO?1FC)(I5AZ&A\CQ!&",
M@D&O2"]J^D/7O?NO=>]^Z]U[W[KW7O?NO=+WJ[K#?O=/8>S^J>K]LY'>/8&_
M<Y1;<VIMO%K&:O*96N?3''Y9Y(:6CI8(U::HJ9Y(J>EIXWFF=(D=PDW"_L]K
MLI=QOY%BLX4+.QX #^9/D *DF@ )/2[:]LO]YW"':MLB::_G<(B+Q9C]M  .
M))("@$D@ GKZ0G\KK^6[L#^79T7!MF 8W<O=^^H<?F.Z.R(:="^5S,4 --M'
M;=3+3PUT&P]IM+(E%%)I>IJ'FK)%1Y_%%A#S]SQ><Z[L9SJCVJ$E8(J\%\W8
M5IXC_B(X"BBH%3T5]L?;JP]O=C%LNF7>IP&N)@/B:F(T- 1%'D*#Q)9R 6H+
M-_8#ZDKKWOW7NO>_=>Z(5_,?^"VT/Y@GQGW'TEG*VCVYN^CKZ/=W5>_*FD>K
M.R]]XE98J:KGAA*SU.$S>+JJG'9&%;EJ6J,B#SQ0.@OY(YMN>3=]3=8@7MB"
MDL8--<9XCY,I 93ZBAP2"!?<3D>TY^Y;DV6=A'=AA)!*17PY5X$TR5924<?P
MM4=P4C6]V9_PEJ[0AW=M>;?WR?Z[K-CPY_$3;PHML;2W1!N.MVS%7P29NBP5
M3D)A0TF6K,<LD=/-,&CAE9797"E3-]U[_P!@;:06=A.+LH=!=TTAJ=I8#) -
M"0,D8QUCI9_=AW,7<1O]SMS9"1?$"1N'*5&H*2:!B*@$X!S0\.MO!MG5&Q>I
MO[@='XS:FTZG:.PEVCU/BLO35YV5MF3"8$8?9E+D:+&L<E/MW"FFIQ+!"ZS2
MT\119%9M8QO^I6[W'ZS=FDD62;7,01K;4VIR"<:FJ:$X!-:>766GT;6.U?0;
M(L4310>' K ^&FE=,8(&2BT%0#4@4J#GK5\V+_PFHW?O+O%^X/EY\LJ/M"DS
M^_*_?79>$VCL_-4FX.R:O(Y$9G*4M=O7,;@IY< N?R,\RU<D%!--'3W6!HY'
M62">[OWSMK7:?W;RWMQMV2$1Q,[J5B &D$(J]VD4H"P!/$$"AQEL?NX7=YO?
M[WYMW47223F698XV#S$G4P,C.-.HDZB%) ^$@FJ[7&&PV)V[A\5M_ 8R@PN"
MP6-H<-A<-BJ2"@Q>)Q.,I8J+&XS&T-*D5-14%!1P)%#%&JI'&@50  />/,LL
MD\K33,7F=BS,34DDU)).22<DGB>LIX88K>%+>!52!%"JJ@!5510* ,  "@ P
M!TY>Z=.=>]^Z]U[W[KW7O?NO=:['\QK^0!LCYG][9+Y"=4]OTG1.[MZQP2]G
MX"MV(V[=L[HW#24\=(F\L8M!N3;=1@LYDJ6"-<E'IJ(:Z=?NB8ZAYVGFKDGW
MBN^5]H79MPMC=VT7]DPDT,BDUT&JL&4&NG@5';D 4Q[]P_86RYRWQN8-JNQ8
MW<P'C*8O$1W IXBT="K$ :QD,>[#%BQ+NTO^$ZGRW[QFZK/:'S#ZGR\O5?6&
MV>F<+G/[C[WKLVVP=I9G/U^W8*[[O*0QY.MV]C-P''TH\E.C45'3QL0RO*PH
MV_WJY<VD7'[OVRY47%PT[+KC"^(ZJ&I08#%=1P>YF/RZ!NZ?=ZYLWLVO[SW>
MT<VMLENK>'(6\*-G* U;)17T+D=JJ#FI.S;\1^@(?BO\:.EOCS#N63>7^B;8
MN*VG/NJ7&KAOX]74OEJ,CDX<0M7D/X92U-?4R&&G:HJ'AATJTLC NT$<Q[P>
M8-]NMZ,?A?4S%]%=6D' %:"I  J:"I\APZR5Y3V$<K\MV7+ZR&;Z2!8R]-.H
MC);34Z02305-!0$GCT8OV2="'KWOW7NO>_=>Z++\JOA]\>_FCUQ+UA\ANO\
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MZ57B: DGT  !))(  ))IUK==VV[8["3=-VF2"PB +.W 5( &*DDD@  $DD
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M,Y\(_P#LHS^9Y_XM_M3_ .!>Z']D/-7_ "1-A_Z5K_\ :5<=";DO_E8>9O\
MI;I_VA6O2*_EXTL,7PV[Z6EIHHWJ?DG\^&D6GA5&GF7Y ]L4L3.(U!ED6G@C
MC4FY"(JC@ >U7.C$\S6>HX%CM_\ VCPG_9Z1>WR <GWX4"IW+=.'G_C4X_P
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M_P !SVW[0<N_\JGS#_SS6G_:;#T9<U?\KORM_P ]=[_W;Y^O?S9O^R&M^?\
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(7NO>_=>Z_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Oct. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  01,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VANDA PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2200 Pennsylvania Avenue NW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300E<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Washington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">DC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">734-3400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VNDA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001347178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">03-0491827<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="vnda-20251001.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vandapharmaceuticals.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="vnda-20251001.htm">vnda-20251001.htm</File>
    <File>vnda-20251001.xsd</File>
    <File>vnda-20251001_lab.xml</File>
    <File>vnda-20251001_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "vnda-20251001.htm": {
   "nsprefix": "vnda",
   "nsuri": "http://www.vandapharmaceuticals.com/20251001",
   "dts": {
    "inline": {
     "local": [
      "vnda-20251001.htm"
     ]
    },
    "schema": {
     "local": [
      "vnda-20251001.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "vnda-20251001_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vnda-20251001_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.vandapharmaceuticals.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentPeriodEndDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vnda-20251001.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentPeriodEndDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vnda-20251001.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.vandapharmaceuticals.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-25-043489-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-043489-xbrl.zip
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MC&#KIK"+8SXJ&%I& 3?0,(2-WL.-7@XH8'I$&#X44T A6%T9A)X*9EPSTA<
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M!3N21OB/X!BV7,=OLKC!-OVS%VSSG%L \?FSG?T.^_7\I/N".9WP,307+)%
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M$T2^+D3NLN6 P]I6%]0LXR4T0&CS-E5\9,& +!YPI436KW@8$TS&Y(8RK#@
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M?U>!OPR_?GSI?W7Y)U!+ 0(4 Q0    ( $2)05NRZ9LMVP\   EW   1
M          "  0    !V;F1A+3(P,C4Q,# Q+FAT;5!+ 0(4 Q0    ( $2)
M05L;,:[C;@(  "H'   1              "  0H0  !V;F1A+3(P,C4Q,# Q
M+GAS9%!+ 0(4 Q0    ( $2)05MW-P-Z4@H  !18   5              "
M :<2  !V;F1A+3(P,C4Q,# Q7VQA8BYX;6Q02P$"% ,4    " !$B4%;<K=#
M,N(&   <,P  %0              @ $L'0  =FYD82TR,#(U,3 P,5]P<F4N
M>&UL4$L! A0#%     @ 1(E!6W%]Q-46#   ?#D  !P              ( !
M020  '9N9&$X+6LQ,#$R,#(U97AH:6)I=#DY,2YH=&U02P4&      4 !0!.
) 0  D3

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>vnda-20251001_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vnda-20251001.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001347178</identifier>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-01</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001347178</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-10-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">VANDA PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-34186</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">03-0491827</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">2200 Pennsylvania Avenue NW</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 300E</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Washington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">DC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">20037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">202</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">734-3400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">VNDA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
